Morehouse School of Medicine Partners With Georgia Tech to Create Health Technology Startups

The Morehouse School of Medicine (MSM), a historically Black educational institution in Atlanta, has partnered with the Georgia Institute of Technology’s Advanced Technology Development Center (ATDC) to launch a new initiative that will support the medical school’s commercialization efforts to create health technology startups (HealthTech).

“We’re excited to forge this effort between our two schools that will help translate ideas that may start in the lab to real-world solutions for minority and rural populations in healthcare,” said James W. Lillard, associate dean for research and director of the Office of Translational Technologies at the Morehouse School of Medicine. “This initiative leverages the research rigor and innovations developing at Morehouse School of Medicine with Georgia Tech’s proven ATDC model of helping technology entrepreneurs create viable, scalable companies.”

The ATDC will provide the historically Black medical school with a full suite of services and educational programming to support entrepreneurship in the HealthTech arena among faculty, staff, and students on the Morehouse campus. The goal of the partnership is to help entrepreneurs gain insight into successful HealthTech commercialization, through the program, which includes curriculum, connections, and coaching.

“This is a great collaborative undertaking that takes our ‘Startup Success, Engineered’ model into the clinical setting and gives particular focus on Black entrepreneurs who are an underrepresented community in tech,” said Kirk Barnes of the Advanced Technology Development Center. “This will help expand the pace and flow of innovation and commercialization of research coming out of the Morehouse School of Medicine as well as give them access to the broader resources at Georgia Tech and the ATDC model will formalize and expedite how that happens.”


Comments (1)

Trackback URL | Comments RSS Feed

  1. Timothy Allen says:

    Blessings. How can the biopharma industry help?

Leave a Reply

Due to incidents of abuse and harassment that have occurred in the past, JBHE will not publish telephone numbers or email addresses of individuals in this space. If you want to contact someone in a particular article, we suggest you contact them directly not in an open forum.